Novel oral nano-amorphous sirolimus formulation to exhibit comparable exposure to intravenously administered temsirolimus: An oral alternative to the treatment of mTOR-responsive malignancies

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 36; no. 15_suppl; p. e16555
Main Authors Glavinas, Hristos, Basa-Dénes, Orsolya, Angi, Réka, Kárpáti, Balázs, Jordán, Tamás, Solymosi, Tamás, McDermott, John, Roe, Chris, McKenzie, Litza, Heltovics, Gabor
Format Journal Article
LanguageEnglish
Published 20.05.2018
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2018.36.15_suppl.e16555